Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.72 USD | +2.64% | +1.12% | -5.88% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 34.93M 25.54M |
---|---|---|---|---|---|
Net income 2024 * | -18M -13.16M | Net income 2025 * | -23M -16.82M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.92
x | P/E ratio 2025 * |
-2.47
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.98% |
Latest transcript on Acasti Pharma Inc.
1 day | +2.64% | ||
1 week | +1.12% | ||
Current month | -2.16% | ||
1 month | -6.21% | ||
3 months | -18.81% | ||
6 months | +28.62% | ||
Current year | -5.88% |
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 21-07-31 |
Director of Finance/CFO | 52 | Jan. 04 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 23-05-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 23-10-09 |
Director/Board Member | - | 23-10-09 | |
Santosh Kottayil
BRD | Director/Board Member | - | 23-10-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 2.72 | +2.64% | 13,639 |
24-05-23 | 2.65 | -1.49% | 12,918 |
24-05-22 | 2.69 | -1.47% | 2,569 |
24-05-21 | 2.73 | +0.92% | 15,779 |
24-05-20 | 2.705 | +0.56% | 13,673 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.88% | 25.57M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- ACST Stock